Dimension Therapeutics is a gene therapy company focused on developing novel therapies to treat rare diseases. The company is focused on building its adeno-associated virus (AAV) therapeutic capabilities and advancing multiple gene therapy programs in rare diseases through partnerships with REGENX Biosciences and the University of Pennsylvania.
Market
Gene Therapy for Rare Diseases
Location
Cambridge,
MA,
USA
Coinvestors
Jennison Associates, New Leaf Venture Partners, OrbiMed Advisors, Partner Fund Management, RA Capital, Rock Springs Capital, Tourbillon Global Ventures